Eledon Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Eledon Pharmaceuticals, Inc. (ELDN) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $359.00 thousand for the 12-month period ending 2024-12-31, per its 10-K/A filed 2025-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2025-08-14
- Eledon Pharmaceuticals, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $359.00K, a 4.01% decline from fiscal 2023.
- Eledon Pharmaceuticals, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $374.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|
| 2024-12-31 | $359.00K 10-K/A · filed 2025-08-14 |
| 2023-12-31 | $374.00K 10-K/A · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |